Abstract:Bioactive peptides exhibit key roles in a wide variety of complex processes, such as regulation of body weight, learning, aging, and innate immune response. Next to the classical bioactive peptides, emerging from larger precursor proteins by specific proteolytic processing, a new class of peptides originating from small open reading frames (sORFs) have been recognized as important biological regulators. But their intrinsic properties, specific expression pattern and location on presumed non-coding regions have hindered the full characterization of the repertoire of bioactive peptides, despite their predominant role in various pathways. Although the development of peptidomics has offered the opportunity to study these peptides in vivo, it remains challenging to identify the full peptidome as the lack of cleavage enzyme specification and large search space complicates conventional database search approaches. In this study, we introduce a proteogenomics methodology using a new type of mass spectrometry instrument and the implementation of machine learning tools toward improved identification of potential bioactive peptides in the mouse brain. The application of trapped ion mobility spectrometry (tims) coupled to a time-of-flight mass analyzer (TOF) offers improved sensitivity, an enhanced peptide coverage, reduction in chemical noise and the reduced occurrence of chimeric spectra. Subsequent machine learning tools MS2PIP, predicting fragment ion intensities and DeepLC, predicting retention times, improve the database searching based on a large and comprehensive custom database containing both sORFs and alternative ORFs. Finally, the identification of peptides is further enhanced by applying the post-processing semi-supervised learning tool Percolator. Applying this workflow, the first peptidomics workflow combined with spectral intensity and retention time predictions, we identified a total of 167 predicted sORF-encoded peptides, of which 48 originating from presumed non-coding locations, next to 401 peptides from known neuropeptide precursors, linked to 66 annotated bioactive neuropeptides from within 22 different families. Additional PEAKS analysis expanded the pool of SEPs on presumed non-coding locations to 84, while an additional 204 peptides completed the list of peptides from neuropeptide precursors. Altogether, this study provides insights into a new robust pipeline that fuses technological advancements from different fields ensuring an improved coverage of the neuropeptidome in the mouse brain.

Combining mass spectrometry and machine learning to discover bioactive peptides

Ion Mobility Coupled to a Time-of-Flight Mass Analyzer Combined With Fragment Intensity Predictions Improves Identification of Classical Bioactive Peptides and Small Open Reading Frame-Encoded Peptides

CSM‐peptides: A computational approach to rapid identification of therapeutic peptides

Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides

Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics

Test-Time Training for Deep MS/MS Spectrum Prediction Improves Peptide Identification.

Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences

Peptide clustering enhances large-scale analyses and reveals proteolytic signatures in mass spectrometry data

Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery.

Ensemble Machine Learning and Predicted Properties Promote Antimicrobial Peptide Identification

Discovery of Proteomics based on Machine learning

Machine Learning-Driven Discovery and Evaluation of Antimicrobial Peptides from Crassostrea gigas Mucus Proteome

Prediction of peptide mass spectral libraries with machine learning.

Improved design and screening of high bioactivity peptides for drug discovery

A Pseudotargeted Peptidomics Strategy for Screening Natural Signature Peptides in Animal-Derived Drugs: Taking Pheretima As a Case

Impact of Machine Learning-Associated Research Strategies on the Identification of Peptide-Receptor Interactions in the Post-Omics Era

High-confidence De Novo Peptide Sequencing Using Positive Charge Derivatization and Tandem MS Spectra Merging.

Machine Learning in Quantitative Protein–peptide Affinity Prediction: Implications for Therapeutic Peptide Design

Challenges in computational discovery of bioactive peptides in 'omics data

Identification of Mouse Brain Neuropeptides by High Throughput Mass Spectrometry

Predicting Peptide Ionization Efficiencies for Electrospray Ionization Mass Spectrometry Using Machine Learning